Proton pump inhibitors as a possible cause of vitiligo: an in vivo and in vitro study.

J Eur Acad Dermatol Venereol

Department of Dermatology, School of Medicine and Research Institute of Medical Sciences, Chungnam National University, Daejeon, Korea.

Published: November 2014

AI Article Synopsis

  • Vitiligo is a skin disorder characterized by the loss of pigment, and some reports suggest that proton pump inhibitors (PPIs) may worsen this condition.
  • Research was conducted to evaluate the impact of PPIs on melanin production in both lab-grown cells and living zebrafish.
  • The study found that PPIs decreased melanin levels and activity of the enzyme involved in pigmentation, indicating that their use could potentially worsen vitiligo in susceptible individuals.

Article Abstract

Background: Vitiligo is an acquired depigmentation disorder of melanocytes. Recently, some clinical reports have suggested that proton pump inhibitors (PPIs) may worsen vitiligo, but their effects on melanocytes have yet to be elucidated.

Objective: We investigated the effect of PPIs on melanogenesis in vivo and in vitro.

Methods: We examined the effect of PPIs on melanogenesis in B16 murine melanoma cells by measuring melanin content and tyrosinase (TYR) activity. TYR and tyrosinase-related protein-1 (TRP-1) were monitored by western blotting. Finally, a PPI was applied to zebrafish embryos to investigate its in vivo effect on pigmentation.

Results: In agreement with our clinical experience of worsened vitiligo after PPI treatment, PPIs decreased both melanin content and TYR activity. Western blotting showed that PPIs decreased TYR and TRP-1 protein levels. In the zebrafish test, PPIs inhibited body pigmentation in a dose-dependent manner.

Conclusion: These results suggest that the functional inhibition of melanization by PPIs may induce or aggravate vitiligo lesions in genetically predisposed patients.

Download full-text PDF

Source
http://dx.doi.org/10.1111/jdv.12317DOI Listing

Publication Analysis

Top Keywords

proton pump
8
pump inhibitors
8
ppis melanogenesis
8
melanin content
8
tyr activity
8
western blotting
8
ppis decreased
8
ppis
7
vitiligo
5
inhibitors vitiligo
4

Similar Publications

Acidification is a key component of digestion throughout metazoans. The gut digestive fluid of many invertebrates is acidified by the vesicular-type H+-ATPase (VHA). In contrast, vertebrates generate acidic gut fluids using the gastric H+/K+-ATPase (HKA); an evolutionary innovation linked with the appearance of a true stomach that greatly improves digestion, absorption, and immune function.

View Article and Find Full Text PDF

An 83-year-old male presented to our Digestive System Department with a 5-day history of severe gastrointestinal (GI) bleeding and a 14-year history of idiopathic thrombocytopenic purpura (ITP) with low platelet levels. Colonoscopy revealed extensive telangiectasias throughout the colon, particularly in the transverse and ascending segments. Standard treatment with proton-pump inhibitors and somatostatin proved ineffective.

View Article and Find Full Text PDF

Fever and diarrhea are the common symptoms of infection (CDI); however, pseudomembranous enteritis, megacolonization, and paralytic ileus have been observed in severe cases. spores are resistant to several types of disinfectants. Thus, they are often the causative pathogens of healthcare-associated infections.

View Article and Find Full Text PDF

Morphological and molecular phylogeny of sp. (Digenea: Clinostomidae) metacercariae, using DNA barcode from a South American freshwater fish.

J Helminthol

January 2025

Universidade Federal de Alagoas (UFAL), Instituto de Ciências Biológicas e da Saúde, Departamento de Patologia e Parasitologia, Maceió, Alagoas, Brasil.

Here, we present a comprehensive morphological and molecular phylogenetic analysis of sp. (Digenea: Clinostomidae) metacercariae parasitizing two freshwater fish species from Southeast Brazil: (piranha) and (tambuatá). The morphological examination revealed distinct characteristics of metacercariae in each host.

View Article and Find Full Text PDF

Background: Proton pump inhibitors (PPIs) are commonly used for managing gastroesophageal disorders but concerns about their potential association with increased stroke risk have emerged, especially among patients with pre-existing cardiovascular conditions such as acute coronary syndrome (ACS). This systematic review and meta-analysis aim to assess the risk of stroke associated with PPI use, stratified by the presence or absence of pre-existing CVD.

Methods: This review was conducted following the PRISMA guidelines and included studies up to March 2024 from PubMed, Embase, and Web of Science.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!